JNJ-38877605
|
K021588-10mg
|
99% |
943540-75-8 |
10mg
|
¥ 4480.0
|
4~8周 |
科威 |
JNJ-38877605
|
K021588-5mg
|
99% |
943540-75-8 |
5mg
|
¥ 2489.0
|
4~8周 |
科威 |
JNJ-38877605
|
K021588-50mg
|
99% |
943540-75-8 |
50mg
|
¥ 12778.0
|
4~8周 |
科威 |
JNJ-38877605
|
K021588-2mg
|
99% |
943540-75-8 |
2mg
|
¥ 1162.0
|
4~8周 |
科威 |
Ponatinib (AP24534)
|
K021587-50mg
|
99% |
943319-70-8 |
50mg
|
¥ 2216.0
|
4~8周 |
科威 |
Ponatinib (AP24534)
|
K021587-250mg
|
99% |
943319-70-8 |
250mg
|
¥ 7055.0
|
4~8周 |
科威 |
Ponatinib (AP24534)
|
K021587-10mg
|
99% |
943319-70-8 |
10mg
|
¥ 845.0
|
4~8周 |
科威 |
4''-叔丁基苯乙酮
|
K001605-5g
|
98% |
943-27-1 |
5g
|
¥ 979.0
|
現(xiàn)貨 |
科威 |
4''-叔丁基苯乙酮
|
K001605-25g
|
98% |
943-27-1 |
25g
|
¥ 3919.0
|
現(xiàn)貨 |
科威 |
4''-叔丁基苯乙酮
|
K001605-1g
|
98% |
943-27-1 |
1g
|
¥ 279.0
|
現(xiàn)貨 |
科威 |
2-硝基對甲基異丙基苯
|
K021586-25g
|
98% |
943-15-7 |
25g
|
¥ 2284.0
|
4~8周 |
科威 |
2-硝基對甲基異丙基苯
|
K021586-5g
|
98% |
943-15-7 |
5g
|
¥ 643.0
|
4~8周 |
科威 |
N-(2''-(R)-hydroxyarachidoyl)-D-erythro-sphingosine
|
K021585-5mg
|
99% |
943147-54-4 |
5mg
|
¥ 3678.0
|
4~8周 |
科威 |
N-(2''-(R)-hydroxyarachidoyl)-D-erythro-sphingosine
|
K021585-50mg
|
99% |
943147-54-4 |
50mg
|
¥ 22280.0
|
4~8周 |
科威 |
N-(2''-(R)-hydroxyarachidoyl)-D-erythro-sphingosine
|
K021585-25mg
|
99% |
943147-54-4 |
25mg
|
¥ 13696.0
|
4~8周 |
科威 |
N-(2''-(R)-hydroxyarachidoyl)-D-erythro-sphingosine
|
K021585-10mg
|
99% |
943147-54-4 |
10mg
|
¥ 6541.0
|
4~8周 |
科威 |
2-溴-5-硝基苯甲酸
|
K001208-25g
|
98% |
943-14-6 |
25g
|
¥ 1133.0
|
4~8周 |
科威 |
2-溴-5-硝基苯甲酸
|
K001208-5g
|
98% |
943-14-6 |
5g
|
¥ 451.0
|
4~8周 |
科威 |
2-氰基-6-甲氧基苯并噻唑
|
K020278-1g
|
99% |
943-03-3 |
1g
|
¥ 1165.0
|
4~8周 |
科威 |
2-氰基-6-甲氧基苯并噻唑
|
K020278-5g
|
99% |
943-03-3 |
5g
|
¥ 4543.0
|
4~8周 |
科威 |
CCT129202
|
K021584-10mg
|
99% |
942947-93-5 |
10mg
|
¥ 5310.0
|
4~8周 |
科威 |
CCT129202
|
K021584-5mg
|
99% |
942947-93-5 |
5mg
|
¥ 2821.0
|
4~8周 |
科威 |
CCT129202
|
K021584-50mg
|
99% |
942947-93-5 |
50mg
|
¥ 16097.0
|
4~8周 |
科威 |
GSK1070916
|
K021583-5mg
|
98% |
942918-07-2 |
5mg
|
¥ 1074.0
|
4~8周 |
科威 |